Literature DB >> 15196621

The Sharp/van der Heijde method out-performed the Larsen/Scott method on the individual patient level in assessing radiographs in early rheumatoid arthritis.

Karin Bruynesteyn1, Désirée van der Heijde, Maarten Boers, Sjef van der Linden, Marissa Lassere, Cees van der Vleuten.   

Abstract

OBJECTIVE: To test the reliability of two radiologic scoring methods in rheumatoid arthritis (RA)--the Sharp/van der Heijde (SvH) and the Larsen/Scott (LS)--with generalizability analyses. STUDY DESIGN AND
SETTING: Films of 51 patients representing the spectrum of early RA were read by two raters for each method. The discriminative ability and responsiveness were expressed as: intraclass correlation coefficients (ICCs), two types of smallest detectable difference (SDD), and two types of smallest detectable change (SDC); reflecting measurement error when discriminating between or detecting changes within (1) individuals or (2) groups. They were calculated for (average) scores of one to three raters.
RESULTS: The discriminative capacity (0.85-0.97) and responsiveness (0.91-0.97) were good when expressed by ICC. On the group level the SDDs and SDCs ranged between 0.6-3.3% of the max. obtainable score. On the individual level, the scores showed better reliability measured with the SvH (SDDs 2.0-3.4%) than with the LS (SDDs 5.3-9.2%). The SvH also assessed changes in scores in individuals with less measurement error (SDCs 1.3-2.2%) than the LS (SDCs 2.3-3.9%).
CONCLUSION: For early RA patients, the SvH seems preferable if analyses on individual level are included.

Entities:  

Mesh:

Year:  2004        PMID: 15196621     DOI: 10.1016/j.jclinepi.2003.10.014

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  10 in total

Review 1.  [Quantitative imaging in rheumatoid arthritis: from scoring to measurement].

Authors:  P Peloschek; G Langs; A Valentinitsch; M Bubale; T Schlager; C Müller-Mang; F Kainberger
Journal:  Radiologe       Date:  2006-05       Impact factor: 0.635

2.  Updating the OMERACT filter: implications for imaging and soluble biomarkers.

Authors:  Maria-Antonietta D'Agostino; Maarten Boers; John Kirwan; Désirée van der Heijde; Mikkel Østergaard; Georg Schett; Robert B Landewé; Walter P Maksymowych; Esperanza Naredo; Maxime Dougados; Annamaria Iagnocco; Clifton O Bingham; Peter M Brooks; Dorcas E Beaton; Frederique Gandjbakhch; Laure Gossec; Francis Guillemin; Sarah E Hewlett; Margreet Kloppenburg; Lyn March; Philip J Mease; Ingrid Moller; Lee S Simon; Jasvinder A Singh; Vibeke Strand; Richard J Wakefield; George A Wells; Peter Tugwell; Philip G Conaghan
Journal:  J Rheumatol       Date:  2014-03-01       Impact factor: 4.666

3.  Early supplemental α2-macroglobulin attenuates cartilage and bone damage by inhibiting inflammation in collagen II-induced arthritis model.

Authors:  Shengchun Li; Chuan Xiang; Xiaochun Wei; Xiaojuan Sun; Ruifang Li; Pengcui Li; Jian Sun; Dinglu Wei; Yong Chen; Yanxiang Zhang; Lei Wei
Journal:  Int J Rheum Dis       Date:  2019-01-04       Impact factor: 2.454

4.  Quantification of Joint Space Width Difference on Radiography Via Phase-Only Correlation (POC) Analysis: a Phantom Study Comparing with Various Tomographical Modalities Using Conventional Margin-Contouring.

Authors:  Aimi Taguchi; Shun Shishido; Yafei Ou; Masayuki Ikebe; Tianyu Zeng; Wanxuan Fang; Koichi Murakami; Toshikazu Ueda; Nobutoshi Yasojima; Keitaro Sato; Kenichi Tamura; Kenneth Sutherland; Nozomi Oki; Ko Chiba; Kazuyuki Minowa; Masataka Uetani; Tamotsu Kamishima
Journal:  J Digit Imaging       Date:  2020-12-02       Impact factor: 4.056

5.  Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up.

Authors:  Mark Houseman; Catherine Potter; Nicola Marshall; Rachel Lakey; Tim Cawston; Ian Griffiths; Steven Young-Min; John D Isaacs
Journal:  Arthritis Res Ther       Date:  2012-02-07       Impact factor: 5.156

6.  Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritis.

Authors:  Meliha C Kapetanovic; Elisabet Lindqvist; Jakob Algulin; Kjell Jonsson; Tore Saxne; Kerstin Eberhardt; Pierre Geborek
Journal:  Arthritis Res Ther       Date:  2011-02-23       Impact factor: 5.156

7.  Computerised versus conventional methodology of radiographic joint destruction assessment in early rheumatoid arthritis.

Authors:  Yinghe Huo; Maria J H De Hair; Yasmin O Shaib; Désirée van der Heijde; Natalia O Kuchuk; Max A Viergever; Jacob M van Laar; Koen L Vincken; Floris P Lafeber
Journal:  RMD Open       Date:  2015-12-09

8.  Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study.

Authors:  Jian-Da Ma; Xiu-Ning Wei; Dong-Hui Zheng; Ying-Qian Mo; Le-Feng Chen; Xiang Zhang; Jin-Hua Li; Jing-Hua Li; Lie Dai
Journal:  Arthritis Res Ther       Date:  2015-10-14       Impact factor: 5.156

9.  Rheumatoid arthritis coexisting with ankylosing spondylitis: A report of 22 cases with delayed diagnosis.

Authors:  Yuanyuan Zhang; Bo Feng; Jing Dong; Yanyan Zhong; Liqin Wang; Lei Zhao
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

10.  A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiated inflammatory arthritis: study protocol for a randomized controlled trial.

Authors:  Ruben Tavares; Karen Anne Beattie; William George Bensen; Raja S Bobba; Alfred A Cividino; Karen Finlay; Ron Goeree; Lawrence Errol Hart; Erik Jurriaans; Maggie J Larche; Naveen Parasu; Jean-Eric Tarride; Colin E Webber; Jonathan D Adachi
Journal:  Trials       Date:  2014-07-05       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.